MLYS
Mineralys Therapeutics, Inc.
25.90$
-2.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -0.53 | -2.92 | -5.65 | -2.24 | -3.43 | -2.10 | |
| – | – | – | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.02 | 0.09 | 0.14 | 0.23 | 0.29 | |
| 0.10 | 0.15 | -0.04 | – | – | – | |
| 0.10 | 0.82 | 0.15 | -0.21 | 0.20 | 0.04 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -4.70 | -4.37 | -4.21 | -4.43 | 2.37 | -5.76 | |
| 0.83 | – | – | – | – | – | |
| 0.00 | – | -0.32 | 0.00 | 0.00 | 0.00 | |
| 0.83 | 0.00 | – | – | – | – | |
| 0.83 | 4.78 | 24.77 | 5.62 | 2.39 | 8.74 | |
| 0.30 | 1.86 | 14.91 | -1.06 | 1.33 | 0.87 | |
| -0.53 | -2.92 | -5.65 | -2.24 | -3.43 | -2.11 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.